Cite
Indoleamine 2,3-dioxygenase 1 in circumventing checkpoint inhibitor responses: Updated.
MLA
Charehjoo, Arian, et al. “Indoleamine 2,3-Dioxygenase 1 in Circumventing Checkpoint Inhibitor Responses: Updated.” International Immunopharmacology, vol. 118, May 2023, p. N.PAG. EBSCOhost, https://doi.org/10.1016/j.intimp.2023.110032.
APA
Charehjoo, A., Majidpoor, J., & Mortezaee, K. (2023). Indoleamine 2,3-dioxygenase 1 in circumventing checkpoint inhibitor responses: Updated. International Immunopharmacology, 118, N.PAG. https://doi.org/10.1016/j.intimp.2023.110032
Chicago
Charehjoo, Arian, Jamal Majidpoor, and Keywan Mortezaee. 2023. “Indoleamine 2,3-Dioxygenase 1 in Circumventing Checkpoint Inhibitor Responses: Updated.” International Immunopharmacology 118 (May): N.PAG. doi:10.1016/j.intimp.2023.110032.